MARKET

SLNO

SLNO

Soleno Therapeutics Inc
NASDAQ
29.51
+1.92
+6.96%
After Hours: 28.99 -0.52 -1.76% 17:07 09/29 EDT
OPEN
26.62
PREV CLOSE
27.59
HIGH
30.29
LOW
24.25
VOLUME
3.01M
TURNOVER
0
52 WEEK HIGH
30.30
52 WEEK LOW
0.8500
MARKET CAP
294.87M
P/E (TTM)
-9.4930
1D
5D
1M
3M
1Y
5Y
Insider Trading: Soleno (NASDAQ:SLNO) Top Insider Buys This Rising Stock
TipRanks · 15h ago
Soleno Therapeutics' 10% owner buys $15M worth of stock
Seeking Alpha · 16h ago
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 1d ago
Soleno Therapeutics prices its underwritten public offering at $20 per share
Seeking Alpha · 1d ago
Jabil, Chico's FAS And Other Big Stocks Moving Higher On Thursday
Benzinga · 1d ago
Acadia Pharmaceuticals, XWELL among healthcare movers
Seeking Alpha · 1d ago
Biotech Stock Roundup: ICPT Up on Buyout Deal, IMVT & PLRX Gain on Study Data
NASDAQ · 1d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 1d ago
More
About SLNO
Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare diseases. The Company’s lead candidate, Diazoxide Choline Extended-Release tablets (DCCR), a once-daily oral tablet for the treatment of Prader-Willi syndrome (PWS), is being evaluated in a phase III clinical development program. DCCR is a potent ATP-sensitive potassium (KATP) channel activator. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine. DCCR’s mode of action with targets in the brain, pancreas and fat tissue has the potential to broadly impact complex diseases like PWS to reduce appetite, reduce food seeking, improve satiety, improve insulin and leptin resistance, and reduce body fat. The Company has a Fast-Track designation for DCCR in PWS and orphan designation for the drug in the United States and the European Union.

Webull offers kinds of Soleno Therapeutics Inc stock information, including NASDAQ:SLNO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLNO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SLNO stock methods without spending real money on the virtual paper trading platform.